RI
LGND icon

Redwood Investments’s Ligand Pharmaceuticals LGND Stock Holding History

Redwood Investments’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-77,345
Closed -$6.33M – 136
2021
Q2 		$6.33M Sell
77,345
-425
-0.5% -$35.4K 0.51% 65
2021
Q1 		$7.4M Sell
77,770
-68,893
-47% -$6.51M 0.65% 57
2020
Q4 		$9.1M Sell
146,663
-21,296
-13% -$1.21M 0.77% 55
2020
Q3 		$9.99M Sell
167,959
-9,475
-5% -$647K 0.84% 56
2020
Q2 		$12.4M Buy
+177,434
New +$11.2M 1.09% 44
2019
Q3 		– Sell
-240,107
Closed -$17.1M – 137
2019
Q2 		$17.1M Sell
240,107
-4,718
-2% -$347K 1.26% 27
2019
Q1 		$19.2M Buy
244,825
+66,466
+37% +$5.04M 1.4% 17
2018
Q4 		$15.1M Buy
178,359
+68,235
+62% +$7.27M 1.42% 18
2018
Q3 		$18.9M Sell
110,124
-34,553
-24% -$5.21M 1.47% 12
2018
Q2 		$18.7M Sell
144,677
-8,900
-6% -$993K 1.29% 29
2018
Q1 		$15.8M Buy
153,577
+9,711
+7% +$960K 1.13% 39
2017
Q4 		$12.3M Buy
143,866
+44,706
+45% +$3.87M 0.87% 57
2017
Q3 		$8.42M Sell
99,160
-14,347
-13% -$1.14M 0.96% 42
2017
Q2 		$8.6M Buy
113,507
+10,978
+11% +$768K 0.87% 56
2017
Q1 		$6.77M Buy
102,529
+314
+0.3% +$20.7K 0.67% 77
2016
Q4 		$6.48M Buy
102,215
+586
+0.6% +$37K 0.59% 81
2016
Q3 		$6.47M Buy
101,629
+54,430
+115% +$4M 0.49% 76
2016
Q2 		$3.51M Sell
47,199
-14,007
-23% -$1.04M 0.32% 86
2016
Q1 		$4.09M Buy
61,206
+31,135
+104% +$1.89M 0.41% 60
2015
Q4 		$2.03M Buy
30,071
+4,654
+18% +$287K 0.22% 78
2015
Q3 		$1.36M Sell
25,417
-30,481
-55% -$1.85M 0.18% 85
2015
Q2 		$3.52M Buy
55,898
+18,787
+51% +$1.03M 0.44% 53
2015
Q1 		$1.78M Buy
37,111
+11,907
+47% +$456K 0.29% 72
2014
Q4 		$837K Sell
25,204
-5,218
-17% -$170K 0.13% 93
2014
Q3 		$892K Buy
30,422
+1,332
+5% +$44.2K 0.12% 93
2014
Q2 		$1.13M Buy
29,090
+6,068
+26% +$246K 0.14% 91
2014
Q1 		$966K Buy
+23,022
New +$960K 0.14% 92

Other funds holding LGND

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
SDJVC
St. Denis J. Villere & Co New Orleans, Louisiana $907M AUM 10.61% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Redwood Investments's LGND Position: Q3 2021 in Review

Redwood Investments sold out of Ligand Pharmaceuticals (LGND) in Q3 2021, closing a stake of 77,345 shares — an estimated $6.33M sold.

Redwood Investments first reported a position in LGND in Q1 2014 and held it in 27 quarters. The position peaked at $19.2M in Q1 2019. 207 funds tracked by Wall St. Rank hold LGND as of Q3 2021.

  • Redwood Investments reported no remaining Ligand Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Redwood Investments sold 77,345 Ligand Pharmaceuticals shares in Q3 2021, an estimated $6.33M.
  • Redwood Investments first reported a position in Ligand Pharmaceuticals in Q1 2014 and held it in 27 quarters.
  • Redwood Investments's Ligand Pharmaceuticals position peaked at $19.2M in Q1 2019.
  • 207 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q3 2021.

Based on Redwood Investments's 13F filing for Q3 2021, filed 19 Oct 2021.